Topiramate 00832-1071-30
- Manufacturer
- Upsher-Smith Laboratories, Llc
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 7, 2014
- Listing Expires
- December 31, 2027
- Application
- NDA205122
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 25 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
00832-1071-30Selected1 BOTTLE in 1 CARTON (0832-1071-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Other packages for this product(2)
500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-1071-15)
1 BOTTLE in 1 CARTON (0832-1071-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE